Invention Grant
- Patent Title: Escherichia coli bacteriophage Esc-COP-9 and use for inhibiting proliferation of pathogenic Escherichia coli thereof
-
Application No.: US16464872Application Date: 2017-09-29
-
Publication No.: US11213050B2Publication Date: 2022-01-04
- Inventor: Seong Jun Yoon , Soo Youn Jun , Hyoun Rok Paik , Jee Soo Son , Sang Hyeon Kang
- Applicant: INTRON BIOTECHNOLOGY, INC.
- Applicant Address: KR Gyeonggi-do
- Assignee: INTRON BIOTECHNOLOGY, INC.
- Current Assignee: INTRON BIOTECHNOLOGY, INC.
- Current Assignee Address: KR Gyeonggi-do
- Agency: Ballard Spahr, LLP
- Priority: KR10-2016-0161324 20161130
- International Application: PCT/KR2017/010957 WO 20170929
- International Announcement: WO2018/101595 WO 20180607
- Main IPC: A23K10/16
- IPC: A23K10/16 ; A23K30/18 ; A61K35/76 ; C12N7/00 ; A01N63/40
Abstract:
The present invention relates to a Siphoviridae bacteriophage Esc-COP-9 (Accession number: KCTC 13131BP) isolated from nature, which has the ability to specifically kill Escherichia coli and which includes a genome expressed by SEQ. ID. NO: 1, and to a method of preventing and treating a pathogenic Escherichia coli infection using a composition including the same as an active ingredient.
Public/Granted literature
Information query
